Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Life Sciences, Biotechnology & Nanotechnology
Reed Smith
Yeah, we know. But you should have seen the EYDDM's smile.
Jones Day
Courts have disagreed over whether Universal Health Services, Inc. v. Escobar, 136 S. Ct. 1989 (2016), announced a mandatory test for implied certification liability under the False Claims Act.
Reed Smith
Just two weeks ago, we largely praised an MDL court's handling of sanctions for a plaintiff's stonewalling in response to discovery obligations, but thought the plaintiff ...
Butler Snow LLP
In this issue of Pro Te (Volume 11, No.2), we examine three important topics with practical implications.
Arnold & Porter
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has recently published a new version of its Code of Practice ...
Reed Smith
We'll get to today's case in a moment, but first, a few words about SCOTUS and expiration dates.
Womble Bond Dickinson
CHARLESTON, S.C.-- The SCBIO 2018 Annual Conference will be the premier gathering of educators, industry leaders and government officials in South Carolina's biotech and pharmaceutical sector.
Arnold & Porter
US antitrust authorities and Congress have long been concerned with promoting competition in the pharmaceutical industry.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
25. (new) A pharmaceutical composition comprising a therapeutic agent effective to reduce the amount of active hsp27 in cancerous cells exposed to the therapeutic agent, and a pharmaceutically...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
On September 4, 2018, the FDA issued final guidance on Physiologically Based Pharmacokinetic Analyses — Format and Content.
Womble Bond Dickinson
The US Food and Drug Administration is considering a proposal that would make it easier for members of the public to obtain information via Freedom of Information Act (FOIA) requests.
Mintz
Over the past couple of years, FDA has introduced multiple programs allowing faster review of medical devices in order to get them to market more quickly.
Baker Donelson
This office has created the Biosimilar Product Development (BPD) Program.
Arnold & Porter
The US Food & Drug Administration (FDA or the Agency) recently unveiled the next phase in the Agency's quest to implement a quality metrics program. On June 29, 2018,
Akin Gump Strauss Hauer & Feld LLP
A three-judge panel of the 9th Circuit ruled that False Claims Act (FCA) plaintiffs must satisfy the two-pronged test for implied false certification claims set out in Universal Health Services, Inc. v. United States ex rel. Escobar.
Reed Smith
One of our primary goals is to bring you the latest and greatest news in the drug and device litigation world.
Duane Morris LLP
Infections caused by surgical procedures are not uncommon and can be life-threatening.
Carlton Fields
In what may be a glimpse into the next frontier in class action litigation, two federal courts recently disposed of putative class actions alleging violations of state privacy laws involving genetic and biometric data.
Oblon, McClelland, Maier & Neustadt, L.L.P
In an interesting, but non-precedential, decision from the Court of Appeals for the Federal Circuit (Supernus Pharmaceuticals, Inc. v TWI Pharmaceuticals, Inc et al), the Court affirmed a decision from the U.S. District Court of New Jersey.
Cadwalader, Wickersham & Taft LLP
A Paris-based pharmaceutical company ("Sanofi") agreed to pay more than $25 million to settle SEC claims that the company falsely recorded improper payments and lacked sufficient internal accounting controls to detect and prevent violations of the Foreign Corrupt Practices Act ("FCPA").
Latest Video
Most Popular Recent Articles
Cadwalader, Wickersham & Taft LLP
Last year, a group of U.S. military veterans and the relatives of troops killed in Iraq filed a lawsuit against several large international pharmaceuticals, accusing them of aiding and abetting terrorism by selling products to Iraq's Ministry of Health which were used to finance operations by the notorious Mahdi Army Group
Cadwalader, Wickersham & Taft LLP
A Paris-based pharmaceutical company ("Sanofi") agreed to pay more than $25 million to settle SEC claims that the company falsely recorded improper payments and lacked sufficient internal accounting controls to detect and prevent violations of the Foreign Corrupt Practices Act ("FCPA").
Cooley LLP
This week a California judge dismissed a lawsuit filed in December 2017 by the Pharmaceutical Research and Manufacturers of America (PhRMA) challenging CA S.B. 17.
Thompson Coburn LLP
In a case of first impression, a federal judge has denied a food company's efforts to lean on the doctrine of preemption to dodge a suit alleging its products were not "all natural" as labeled.
Oblon, McClelland, Maier & Neustadt, L.L.P
In an interesting, but non-precedential, decision from the Court of Appeals for the Federal Circuit (Supernus Pharmaceuticals, Inc. v TWI Pharmaceuticals, Inc et al), the Court affirmed a decision from the U.S. District Court of New Jersey.
Morrison & Foerster LLP
This month, we highlight significant developments from July 2018, including the FDA's Biosimilar Action Plan for "reducing gaming of FDA requirements or other attempts to unfairly delay competition" ...
Fish & Richardson PC
On July 18, 2018, FDA released its "Biosimilars Action Plan" ("BAP") for balancing innovation and competition, accompanied by a press release from FDA Commissioner Scott Gottlieb.
Reed Smith
We confess – when we first considered the spate of eye drop class actions a few years ago, we had trouble taking them seriously.
Reed Smith
Walter White, the high school chemistry teacher turned methamphetamine "manufacturer" and main protagonist in the TV show Breaking Bad, has been called a lot of things.
Fenwick & West LLP
Despite significant market volatility at the start of the year, life sciences and technology IPOs around the world came out strong in H1 2018, with no slowdown in sight.
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with